From Records to Reason
How cliexa advanced explainable clinical AI with Mayo Clinic Platform
Discover how cliexa advanced a clinically grounded AI architecture into a Mayo ClinicPlatform-qualified opioid use disorder solution with measured fairness outcomes and a pathway to enterprise deployment.
From promising architecture to commercial readiness
Clinical AI must deliver more than accurate predictions. It must demonstrate explainability, rigorous validation, responsible AI practices, and enterprise readiness.
Through its work with Mayo Clinic Platform, cliexa advanced a dual-layer architecture combining deterministic clinical rules with predictive AI, progressing through clinical and technical validation, research using de-identified data, qualification, and deployment preparation.
Inside the case study
Learn how cliexa:
- Developed and validated an explainable opioid use disorder risk model
- Achieved 82.3% test accuracy
- Reduced the age-based accuracy gap by 59%
- Prepared an EMR-agnostic, enterprise-ready solution

Download the case study
See how acceleration, discovery, qualification, and deployment capabilities helped cliexa progress from clinical validation to commercial readiness.